Coverage dated September 8, 2026 to September 10, 2026
Federal Appeals Court hears arguments in Louisiana on abortion pill
Headline from WGNO New Orleans, on the newest of 3 developments
The fight over access to abortion pills by mail and through pharmacies continues. The Fifth Circuit Court of Appeals heard arguments from Attorney General Liz Murrill and the FDA over mifepristone restrictions in Louisiana.
WGNO New Orleans's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
3 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Federal judges hear abortion pill case
Headline from Arkansas Democrat-Gazette ·
An appeals court is considering a push to restrict most common abortion method
Headline from The Columbian ·
Newest
Federal Appeals Court hears arguments in Louisiana on abortion pill
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story Federal court to hear arguments on abortion pill access A three-judge panel on the 5th U.S. Circuit Court of Appeals in New Orleans will hear arguments Wednesday in a case that could eventually restrict the nationwide …
In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
Mifepristone challenges have hit repeated snags at Supreme Court on legal standing, and appeals court that twice ruled relaxed prescribing rules violated regulatory procedure is wary of getting overturned again.
A federal appeals court will consider on Wednesday whether to restore restrictions on mailing the abortion-inducing drug mifepristone, testing a Biden-era policy that judges have faulted for inadequate safety analysis and the Trump administration has declined to defend on its merits.
A panel of federal judges is set to hear arguments Wednesday over whether prescribing rules should be tightened for a key drug used in the most common abortion method in the United States.
A federal appeals court today will again hear a lawsuit designed to restrict abortion access nationwide by banning mail and pharmacy dispensing of mifepristone, a safe and effective medication used in two-thirds of U.S. abortions as well as for miscarriage care . The hearing before the U.S.
By Tierney Sneed, CNN (CNN) — The issue of medication abortion was back before a New Orleans-based appeals court on Wednesday, in the latest iteration of a yearslong legal effort to end the provision of abortion drugs via telehealth.
A federal appeals court Wednesday heard arguments in a case that could eventually wipe out access to medication abortion, even in blue states that protect abortion. A three-judge panel of the 5th U.S. Circuit Court of Appeals peppered questions on attorneys for Louisiana, the Food and Drug Administr…
The fight over access to abortion pills by mail and through pharmacies continues. The Fifth Circuit Court of Appeals heard arguments from Attorney General Liz Murrill and the FDA over mifepristone restrictions in Louisiana.
A panel of federal judges heard arguments Wednesday over whether prescribing rules should be tightened for a key drug used in the most common abortion method in the United States, one of several ongoing efforts to restrict abortion access four years after the U.S.
A U.S. appeals court on Wednesday appeared skeptical of a bid by the Republican-led state of Louisiana to curtail access to the abortion drug mifepristone by blocking a 2023 rule that allowed the medication to be prescribed via telemedicine and…
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Related updates
Separate coverage close to this update in time and subject.
